All In Biotech

Drug Trial Radar · NCT07722962

Additional Phase 3 Study of KP-100IT in Subjects With Acute Spinal Cord Injury

An Additional Phase 3, Multicenter Study of Intrathecal Administration of KP-100IT in Subjects With Acute Spinal Cord Injury

Last checked: Nov 19, 2026Latest source record: Jul 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruitingPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Not yet recruiting

Enrollment

10

Planned (sponsor's estimate)

Start

Jul 31, 2026

Primary completion

Dec 31, 2028

Study completion Dec 31, 2028

Sponsor

Lead sponsor
Kringle Pharma, Inc.Industry
Sponsor type
Industry
First posted
Jul 23, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 89 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a Phase 3, multicenter, open-label, single-arm additional study to evaluate the efficacy of intrathecal KP-100IT in patients with acute spinal cord injury. Eligible patients will receive KP-100 0.6 mg/body by intrathecal administration once per week for a total of 5 doses and will be followed for approximately 24 weeks after the first dose.

Conditions

  • Acute Spinal Cord Injury (SCI)

Interventions

  • KP-100ITDrug

    The contents of each vial were dissolved in the distilled water for injection, and the study drug (0.6 mg as KP-100) was administered intrathecally once per week a total of 5 times.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of subjects with an improvement of at least two AIS (American Spinal Injury Association) grade, A to C/D, at 24 weeks after administration, 24 weeksTime frame: 24 weeks after investigational product administration

Locations

3 sites in 1 country. Site status is shown where the registry gives one.

  • Japan Organization for Occupational Health and Safety Comprehensive Spinal Cord Injuries Center

    Iizuka, Fukuoka, Japan

  • Japan Organization for Occupational Health and Safety Hokkaido Spinal Cord Injury Center

    Bibai, Hokkaido, Japan

  • National Hospital Organization Murayama Medical Center

    Musashimurayama, Tokyo, Japan

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.